Alcor takes care of standby (they’ll send a team to camp out at your deathbed) and transportation. CI requires contracting with Suspended Animation for that level of care. Alcor invests more money per patient to fund liquid nitrogen and other maintenance expenses. ($25,000 for neuros and $65,000 for whole body)
On the other hand, CI keeps a relatively low profile while Alcor doesn’t.
Of course I came to the above link and also to CI’s comparison page, still it would be nice to see some independent review of both companies. Especially on the financial prospects.
The information on trust is interesting. Does it mean that Alcor patients have a safer future in case the operation of Alcor is endangered?
What I found strange is that Alcor advertises itself as the only company using “perfusion technology” whatever it means as opposed to CI, whereas CI also insists on using the “best techniques currently available” and cites the same paper as Alcor. It is definitely unclear. The only clear dinstinction seems to be that Alcor uses full body vitrification if a premium is payed. Still, the price difference between 88K and 35K are staggering, even if the transportation/suspension costs are taken into account.
There’s some information here.
Alcor takes care of standby (they’ll send a team to camp out at your deathbed) and transportation. CI requires contracting with Suspended Animation for that level of care. Alcor invests more money per patient to fund liquid nitrogen and other maintenance expenses. ($25,000 for neuros and $65,000 for whole body)
On the other hand, CI keeps a relatively low profile while Alcor doesn’t.
Thanks for the effort!
Of course I came to the above link and also to CI’s comparison page, still it would be nice to see some independent review of both companies. Especially on the financial prospects.
The information on trust is interesting. Does it mean that Alcor patients have a safer future in case the operation of Alcor is endangered?
What I found strange is that Alcor advertises itself as the only company using “perfusion technology” whatever it means as opposed to CI, whereas CI also insists on using the “best techniques currently available” and cites the same paper as Alcor. It is definitely unclear. The only clear dinstinction seems to be that Alcor uses full body vitrification if a premium is payed. Still, the price difference between 88K and 35K are staggering, even if the transportation/suspension costs are taken into account.